Baseline characteristics of major depressive disorder patients in clinical trials in Europe and United States: Is there a transatlantic difference?

Journal of Psychiatric Research

Volumn 35, Issue 2, 2001, Pages 71-81

  Niklson, I A ^a,b   Reimitz, P E ^a  

^a Research and Development   (Netherlands)

^b UCB PHARMA   (Belgium)

Author keywords

Antidepressant trials; Baseline patient characteristics; Clinical trial methodology; Transatlantic difference

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGITATION; ANAMNESIS; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; EUROPE; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; POPULATION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; REPRODUCIBILITY; SAMPLE; SLEEP DISORDER; SOMATIZATION; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CLINICAL TRIALS; CROSS-CULTURAL COMPARISON; DEPRESSIVE DISORDER, MAJOR; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PERSONALITY INVENTORY; PSYCHOMETRICS; SELECTION BIAS; TREATMENT OUTCOME; UNITED STATES;

EID: 0034983037     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00011-5     Document Type: Article

References (26)

1. Do volunteer subjects bias clinical trials?
2. Efficacy of moclobamide in different patient groups. Results of new sub-scale of the Hamilton Depression Rating Scale
3. The Atlantic gap: Clinical trials in Europe and the United States
4. The Hamilton depression scale. Evaluation of objectivity using logistic models
5. Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression
6. A comparison of placebo responders and non-responders in subgroups of depressive disorder
7. Symptomatic volunteers: Another patient dimension for clinical trials
8. Placebo as a treatment for depression
9. Clinical features of depressed patients who do and do not improve with placebo
10. Symptomatic volunteers in multicenter drug trials
11. UK and US health-care systems: Divided by more than a common language
12. Cross-cultural differences in depression
13. Which depressions respond to placebo
14. Comparison of solicited and nonsolicited female unipolar depressives for treatment outcome research
15. Comparison between zimleldin and amitryptiline of efficacy and adverse symptoms - A combined analysis of four British clinical trials in depression
16. Generalizability of treatment studies utilising solicited patients
17. A comparison of patients with major depressive disorder recruited through newspaper advertising versus consultation referrals for clinical drug trials
18. Factors that influence the outcome of placebo controlled antidepressant clinical trial
19. Predictors of therapeutic benefit from amitriptyline in mild depression: A general practice placebo-controlled trial
20. A comparison of demographic variables, symptom profiles and measurements of functioning in symptomatic volunteers and an outpatient clinical population
21. A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders
22. The introductory placebo washout: A retrospective evaluation
23. Severity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclobamide versus placebo
24. Symptomatic volunteers in depression research: A closer look
25. Predictors of placebo response: A retrospective analysis